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Abstract
Background: Patient Reported Outcome (PRO) measurements have become an important tool to evaluate
disease-related quality of life. The “International Hip Outcome Tool” (iHOT12) is a self-administered patient-reported
outcome tool, which includes questions on the patient’s symptoms, functional and sports limitations as well as social,
emotional, and occupational limitations. The purpose of this study was to adapt and validate a German version of the
iHOT12 according to the COSMIN checklist.
Methods: In order to validate the German translation of the iHOT12, we conducted a prospective multicenter cohort
study on patients with hip disorders and a score ≥4 on the modified Tegner Activity Scale (mTAS). The patients
completed the German iHOT12 questionnaire and other functional scores (Hip Outcome Score, modified Tegner Activity
Scale, EuroQol-5D) twice at intervals of at least two weeks. Evaluation of psychometric properties was conducted
following the COSMIN checklist for validation of health status measurement instruments. The methodical testing
for reliability included internal consistency, test-retest reliability, and measurement error. For testing of validity,
we analyzed construct validity, hypotheses testing, interpretability and responsiveness.
Results: Between December 2013 and December 2014, eighty-three consecutive patients completed both
questionnaires and were available for data analysis. Cronbach’s alpha was 0.94 (95 %-CI: 0.91, 0.95) confirming
internal consistency and test-retest reliability of the iHOT-12 was high with an ICC = 0.94 (95 %-CI: 0.89, 0.97). All a
priori hypotheses were confirmed. Further, no relevant floor- or ceiling effects occurred. The iHOT12 showed
good responsiveness with a minimal important change (MIC) under 14 points.
Conclusions: The German translation of the iHOT-12 is a reliable, valid, and responsive tool for the evaluation of
disease-related quality of life in active patients with a hip disorder. We could show that the minimal important
change, a change of health condition the patient discerns, is less than 14 points in the iHOT12 scale.
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Background
Patient-reported outcome (PRO) measurements have be-
come an important tool to evaluate activities, limitations
in everyday life and the quality of life. Conventional
questionnaires focus on patients with osteoarthritis or
undergoing hip arthroplasty with a limited activity level
[1–4]. Over the last decade, the better understanding of
specific hip pathologies has evolved joint preserving pro-
cedures such as hip arthroscopy or surgical hip disloca-
tion [5]. The mainly young and active patients
undergoing these joint preserving procedures have dif-
ferent expectations and aims of their surgery. Conven-
tional outcome tools do not reflect their situation
adequately [6–8]. Further therapeutic innovations are
likely to achieve only minor improvements. With a high
discriminatory power, these instruments can reveal
minor outcome differences.
Recently, the Multicenter Arthroscopy of the Hip Out-
comes Research Network (MAHORN) study group de-
veloped a new PRO questionnaire with special concern
for young, active patients with hip disorders [9]. Com-
pared to other questionnaires, the iHOT includes inquir-
ies of limitations in social interactions, emotional issues
and working life. The original score consisted of 33
items and is validated in English, Spanish, and German
language [9–11]. There is also a short version of 12
items available in English and Spanish language [12].
The iHOT has shown a high reliability and validity.
Studies evaluating measurement properties have to
meet a high methodological quality. The COSMIN
checklist (COnsensus based Standards for the selection
of health status Measurement INstruments) is a
consensus-based checklist to evaluate the methodo-
logical quality of studies on measurement properties of
health status measurement instruments based on an
international Delphi study in 2010 [13].
The purpose of this study was to validate a German
version of the iHOT-12 according to the COSMIN
checklist and compare the psychometric properties of
the short version (iHOT12) to the extended version
(iHOT33).
Methods
International Hip Outcome Tool (iHOT)
In 2012, the Multicenter Arthroscopy of the Hip Out-
comes Research Network (MAHORN) developed the
International Hip Outcome Tool, a self-administrated
questionnaire originally comprising of 33 items. [9]. The
patient is asked to consider the problems of the past
month and to indicate the severity on a 100 mm hori-
zontal line (visual analogue scale) by marking it with a
slash. Each question has equal weight so that the mean
of all questions amounts to the score result ranging from
0 to 100. A score of 100 indicates full function and no
symptoms, whereas a score of zero signifies maximum
limitations and extreme symptoms. There is also a short
form of 12 items available (iHOT-12). The iHOT has
shown a high internal consistency, construct validity,
and responsiveness [8, 9, 14–16].
Adaption of the iHOT-12
The translation of the iHOT-12 into German was carried
out following the guidelines of the American Academy
of Orthopedic Surgeons (AAOS) Outcomes Committee
[17]. According to these guidelines, an informed and an
uninformed translator translated the iHOT-12 from
English into German independently. After consolidation
of both translations, a German linguist reviewed the
German version of the questionnaire. Two native speak-
ing translators (informed and uninformed) re-translated
this German version into English. This version was veri-
fied for consistence. Finally, the German questionnaire
was tested for comprehensibility in 20 patients with a
hip disorder. The translation process was supervised and
documented in a survey report.
Validation study
We performed a prospective multicenter study to evalu-
ate reliability, validity, and responsiveness of the German
version of the iHOT-12. Inclusion criteria were a history
of a hip disorder, a score of ≥4 on a modified Tegner
Activity Scale [18], and sufficient reading and compre-
hension capacity. Patients were excluded if they had a
disorder of the back or the contralateral lower extremity,
a score less than 4 on the modified Tegner Activity
Scale, a mental disorder, or a lack of informed consent
to participation [9]. All patients are seen in an outpatient
setting. The patients primarily completed the question-
naire before seeing the orthopedist. For evaluation of
test–retest reliability, the patients completed a second
questionnaire after a minimum of two weeks. The pa-
tients were asked to answer the questions according to
their current status and return the forms by mail. We
reminded all patients who did not answer within six
weeks by telephone. All patients had given their written
informed consent to participate in this study. The Re-
gensburg University Ethics Committee approved the
study in November 2013 (Institutional Review Board
Number 13-101-0259).
Questionnaire
In addition to the iHOT-12, the questionnaire consisted
of the following scores:
Hip Outcome Score (HOS)
The HOS is an established 31-item PRO tool to evaluate
activities, limitations in everyday life, and quality of life
of patients with a hip disorder. It comprises of two
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subscales on activity of daily life and sports activities.
The patient is asked to answer the questions considering
the past week. Scores range 0–100, higher scores repre-
sent a better function and a higher level of activity [19].
The HOS has been validated and published in German
in 2011 [20].
Modified Tegner Activity Scale (mTAS)
The TAS is a 10 level activity scale reflecting the pa-
tient’s currently highest level of sports activity or other
routine activities. Initially it was designed as a comple-
ment to other functional scores of the knee joint and is
the most commonly used activity scoring tool [18]. Al-
though there is no validation study of the hip modifica-
tion of the TAS, it is also well established and widely
used [9, 12, 16, 21]. A score greater than 4 was an inclu-
sion criterion for the evolution study of the iHOT-33 by
Mohtadi [9]. Hence, we included the scale to our ques-
tionnaire to achieve a similar cohort.
EuroQol-5D (EQ 5-D)
The EQ 5-D is a global quality of life questionnaire con-
sisting of a 5-item assessment of the health status
regarding mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression [22]. The second part
of the EQ 5-D consists of a 200 mm analogue scale con-
cerning the patient’s assessment of the current global
health status. The EQ 5-D has been adapted to German
and is validated for a number of health compromising
conditions [23].
Subjective assessment
The patient was asked to assess his current limitations
concerning function (pain, ROM, etc.), sport/leisure ac-
tivities, employment/housekeeping, and social inter-
action/quality of life. The limitations should be
estimated in percent from 0 % = no limitation at all to
100 % =maximum.
The second set of questions also included an evalu-
ation of whether the condition of their hip joint was
‘much better’, ‘somewhat better’, ‘unchanged’, ‘somewhat
worse’, or ‘much worse’ compared to the primary
evaluation.
Statistical analysis
Questionnaires with any missing data or unclear marking
were excluded from the analysis. Statistical analysis was
performed using the software package SPSS (Version 23,
SPSS Inc., Chicago, Illinois). Unless otherwise stated, de-
scriptive data are given as mean ± standard deviation. The
level of significance was defined at p < 0.05 for all tests.
Methodological testing according to the COSMIN
checklist
Reliability
Reliability is the degree to which the measurement is
free from measurement error [24]. To evaluate reliabil-
ity, internal consistency, test-retest reliability, and meas-
urement error are calculated.
Internal consistency
Internal consistency is described as the degree of inter-
relatedness among items [24]. Sufficient internal
consistency was assumed for a Cronbach’s α greater than
0.7 [25].
Test–retest reliability
Test–retest reliability is the extent to which results of
the same patient in the same health condition remain
unchanged over time [24]. According to the recommen-
dation of the COSMIN manual, the retest was per-
formed after a minimum of two weeks after outpatient
consultation to avoid recollection of the answers and
changes in health condition. Intraclass correlation coeffi-
cients (ICC) were calculated for all patients indicating
an unchanged condition of their hip joint since the pri-
mary evaluation. For an ICC greater than 0.7 sufficient
test-retest reliability was assumed [25].
Measurement error
The measurement error is the systematic and random
error of a patient’s score that is not attributed to true
changes in the construct to be measured [24]. The
Standard Error of Measurement (SEM) was calculated
using the formula SD / √1-ICC (SD = Standard Devi-
ation; ICC = Intraclass correlation coefficient) [25]. The
smallest detectable change (SDC) reflects the smallest
individual change in score that can be interpreted as a
real change. It was calculated by the SEM × 1.96 × √2/
√n [25].
Validity
Validity is the degree to which a questionnaire measures
the construct it purports to measure [24].
Construct validity
Since there is no gold standard in the measurement of
PRO, validity is determined by assessing construct valid-
ity. Construct validity is the degree to which the scores
of a questionnaire are consistent with questionnaires
measuring the same construct. To validate the German
translation of the iHOT12, Spearman’s correlation coef-
ficient was calculated between the iHOT12 and the
other functional scores as well as the subjective rating
by the patient. For a correlation coefficient r < 0.3 a poor
and for r > 0.7 a good correlation was assumed.
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Hypothesis testing
To analyze construct validity we tested a priori hy-
potheses [24]. We hypothesized that the iHOT12
would correlate well with the other subjective scales
like the HOS and the EQ-5D. Therefore, we ex-
pected a Spearman’s correlation coefficient r > 0.7.
We expected a low correlation (r < 0.3) between the
iHOT12 and the mTAS. We correlated the subjective
global rating of change (GRC) with the mean differ-
ence between the iHOT12 scores at T2-T1. We hy-
pothesized that the changes in the iHOT12 score
would correlate with the subjective evaluation of the
patient [21, 26].
Responsiveness
Responsiveness is the ability of a questionnaire to detect
a change over time in the construct to be measured [24].
According to Terwee et al. [25], responsiveness was
demonstrated by comparing the smallest detectable
change (SDC) to the minimal important change (MIC).
Responsiveness was confirmed if the SDC <MIC. Add-
itionally we used an anchor-based method to evaluate
responsiveness [27]. At T2 the patients were asked to
rate whether the current condition of their hip joint was
‘much better’, ‘somewhat better’, ‘unchanged’, ‘somewhat
worse’, or ‘much worse’ compared to the condition of the
primary evaluation.
Interpretability
Interpretability is the ability to transform a qualitative
effect into a quantitative score [24]. The minimal im-
portant change (MIC) was estimated by dividing the
standard deviation (SD) by two as described by Norman
et al. [28]. The effect size (ES) was calculated by the
mean change of the score/SD. The 95 %-CI of the effect
size of the “somewhat better” group was compared to
the ES of the “unchanged” group to estimate the true
MIC (Fig. 1).
Another quality criterion for content validity is the ab-
sence of floor and ceiling effects. If more than 15 % of
patients score highest (100) or lowest (0) value in the
iHOT12, extreme outcome values might not be repre-
sented adequately [25].
Results
Demographic data and generalizability
Between December 2013 and December 2014 eighty-
three patients completed both questionnaires and were
available for data analysis. The cohort comprised of 24
women (29 %) and 59 men (71 %). The mean age was
33.7 ± 11.8 years (range 14–63). Demographic data and
diagnosis-related score results are provided in Table 1.
The second questionnaire was completed on average
28.5 ± 31.7 days (range 14–194) after the first. Missing
items were found in 92 of 5146 items in total (1.8 %).
Questionnaires containing missing items or unclear
marking were excluded from the analysis. Missing items
occurred randomly, there was no accumulation of miss-
ing items in any unit of the questionnaire.
Reliability
A Cronbach’s alpha of 0.94 (95 %-CI: 0.91, 0.95) showed
excellent internal consistency for the iHOT12. The
intraclass correlation coefficient (ICC) was 0.94 (95 %-
CI: 0.89, 0.97) for all patients indicating an unchanged
condition of their hip joint since their primary evalu-
ation (n = 46). The overall SEM was 6.75. Hence, the
smallest detectable change (SDC) reflecting the smallest
individual change in score that can be interpreted as a
real change was 2.76.
Validity
The assessment of the construct validity showed a good
correlation between the iHOT12, HOS and EQ-5D
(Table 2). There was an excellent correlation of r = 0.97
(p < .001) between iHOT 12 and iHOT33 (Fig. 2). Fig. 3
shows the variance accounted expressed as a percentage,
by the inclusion of increasing number of items in the
questionnaire. With a Spearman’s correlation coefficient
of r = 0.03, there was only a poor correlation between
iHOT12 and the mTAS. Therefore, all hypotheses could
be confirmed. Adequate responsiveness of the iHOT12
could be demonstrated with a higher value of MIC
(13.79) compared to SDC (2.76). According to the GRC
dependent 95 %-CI of the ES, the estimation of ES was
confirmed (Fig. 1). In addition, there was a good correl-
ation between the global rating of change (GRC) and the
mean difference between the iHOT12 scores at T2-T1
Fig. 1 Estimation of the effect size by indication of the 95-CI for unchanged and somewhat better subgroups
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(Table 3 and Fig. 4) (r = 0.48, p < .001). According to the
ES of 0.55 the minimal important change, a change that
reflects a clinically relevant improvement is approxi-
mately fourteen points on the iHOT12. The change of
scores for iHOT12 and iHOT33 is shown in Fig. 5.
There was no relevant floor effect for the iHOT12,
since there was only one patient with a score value of
zero (1.2 %). Six patients (7.2 %) scored a maximum
score of 100, which is why relevant ceiling effects could
be declined.
Discussion
The present study evaluated the German version of the
iHOT12. The short form of the iHOT is a quickly ad-
ministrable and easy to use PRO instrument. This
German version of the iHOT12 provides sufficient valid-
ity, reliability, and responsiveness for the evaluation of
physically active patients with non-arthritic hip prob-
lems. There is excellent correlation of the iHOT12 to
the extended version of the iHOT33.
Since femoro-actetabular impingement syndrome
(FAI) has been identified as a risk factor for osteoarth-
ritis of the hip joint, the development of joint preserving
procedures has been advanced in the last decade. Due to
technical improvements, hip arthroscopy has become a
successful procedure to relieve pain and to restore clin-
ical function in FAI [5, 8, 29–32]. Patient-reported out-
come tools are becoming more and more important to
reflect the patient’s view of the postoperative outcome
and limitations in everyday life. Recently, some question-
naires were developed to evaluate the postoperative out-
come in this cohort of young, physically active patients.
These questionnaires mainly focus on symptoms and
function in everyday life [2–4]. Most of them, however,
do not give a comprehensive picture of the patients’
views. Some authors have already pointed out a discrep-
ancy between functional results and patient satisfaction
in patients undergoing hip arthroscopy [5–7, 33, 34]. So-
cial, emotional, and occupational factors might also play
an important role in the patients’ assessment of the ther-
apy. Therefore, the Multicenter Arthroscopy of the Hip
Outcomes Research Network (MAHORN) has devel-
oped an outcome measurement instrument including
questions on social, emotional, and occupational limita-
tions. The iHOT has also been cross-culturally adapted
into Spanish, Portuguese and Swedish [11, 35, 36]. Re-
cent comparative studies have shown good results for
most of the psychometric properties of the iHOT12
[4, 9, 12, 15, 36]. Our study also showed a high level of
reliability and validity for the German version of the
iHOT12.
Study design and population
Our demographic data are comparable to other studies
on young active patients generally undergoing hip arth-
roscopy with an average age around 35 years [6–8, 15,
32, 33]. In order to get a more heterogeneous patient
sample, we did not preselect patients according to their
diagnosis or intended treatment. Aiming for validation
data for various hip diseases, we included all patients
with a hip disorder and an activity level greater than 4
on the modified Tegner activity scale (mTAS). Com-
pared to the original publication of the iHOT by
Mohtadi [9] we chose more liberal inclusion criteria
sparing a limitation of age. We nonetheless excluded
patients with a disorder of the back or the contralateral
lower extremity or a mental disorder to avoid
Table 1 Demographic data and diagnosis related score results
Diagnosis Number of
patients
Mean age Gender iHOT-12 HOS mTAS
male female
FAI 31 (37.3 %) 28.5 (±9.6) 26 5 54.2 (±19.7) 81.6 (±12.6) 5.9
Osteoarthritis 16 (19.3 %) 47.4 (±9.0) 12 4 52.7 (±29.4) 76.9 (±17.0) 4.3
Hip dysplasia 13 (15.7 %) 24.7 (±8.2) 5 8 45.7 (±15.6) 78.9 (±10.2) 5.6
Muscular imbalance 6 (7.2 %) 31.7 (±11.1) 3 3 65.8 (±18.9) 85.2 (±6.9) 5.3
Not specified 17 (20.5 %) 37.4 (±7.7) 13 4 63.9 (±40.4) 82.2 (±23.5) 4.9
Total 83 (100 %) 33.7 (±11.8) 59 24 55.8 (±27.0) 80.9 (±15.7) 5.3
Table 2 Spearman’s correlation coefficients between functional scores
n = 83 G-iHOT 12 G-iHOT 33 HOS mTAS EQ5D
G-iHOt 12 1 0.97 (p < 0.001) 0.85 (p < 0.001) 0.03 (p = 0.808) 0.78 (p < 0.001)
G-iHOt 33 - 1 0.87 (p < 0.001) 0.07 (p = 0.558) 0.77 (p < 0.001)
HOS - - 1 0.02 (p = 0.869) 0.73 (p < 0.001)
mTAS - - - 1 0.02 (p = 0.835)
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Fig. 2 Relation between IHOT 33 and iHOT 12 scores for validation data
Fig. 3 Variance (information) accounted for, expressed as a percentage, by the inclusion of increasing number of items in the questionnaire
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confounding. The number of patients included in our
study is according to previous recommendations [25].
The translation process was conducted according to
the guidelines of the American Academy of Orthopedic
Surgeons (AAOS) Outcomes Committee [17]. We chose
the period of time between test and retest to be a mini-
mum of two weeks as recommended in the COSMIN
checklist [24]. The validation was carried out following
the complete COSMIN checklist [13, 24]. Along with
the prospective multicenter design, the study meets high
methodological standards with a level of evidence Ib.
Reliability
The good correlation coefficient for Cronbach’s alpha
outlines the quality of the German iHOT12 and con-
firm the results of prior validation studies on the iHOT
[9, 12, 15, 36]. Accordingly, an ICC of 0.94 confirmed
excellent test-retest reliability. Low values for measure-
ment error and smallest detectable change (SDC)
indicate that small clinical changes can be detected not
only at group level but also at the individual level [25].
Validity
For the evaluation of the construct validity, the HOS
and EQ-5D seemed most appropriate because they are
applicable in this patient population and validated in the
German language [20, 22, 23]. The HOS was also devel-
oped for patients undergoing hip arthroscopy [20].
Therefore, it seemed a viable instrument to evaluate
construct validity. We determined a sufficient level of
activity by including only patients with an activity level
greater than four on the mTAS as described by Mohtadi
et al. [9]. Because the mTAS is solely derived from the
level of sports activity, it is rather robust to smaller
changes of the medical condition. Therefore, we ex-
pected a rather poor correlation between the functional
hip scores and the mTAS.
Griffin et al. [12] proved similar characteristics of the
short version (iHOT12) compared to the extended
Table 3 Change sensitivity of the iHOT12 based on global rating of change
Global rating of change (GRC) N Mean difference SD Mean difference 95 %-CI Minimum Maximum Effect size (ES) ES 95 %-CI
Somewhat worse 6 −11.01 17.08 −28.94 6.91 −30.00 16.25 -.64 −1.51 0.27
Unchanged 46 3.30 12.69 -.46 7.07 −14.33 63.75 .26 −0.03 0.55
Somewhat better 22 6.54 10.19 2.02 11.06 −19.00 30.17 .64 0.18 1.10
Much better 9 39.07 32.71 13.93 64.22 −7.83 93.50 1.19 0.30 2.04
Fig. 4 Boxplots of the iHOT12 for global rating of change categories
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version (iHOT33). The excellent correlation between the
iHOT12 and the iHOT33 in our study supports their as-
sumption that for clinical use, the 12 questions of the
short version are sufficient.
Responsiveness and interpretability
In our population, the minimal important change (MIC)
according to the method of Norman et al. [28] was
13.79. There was a larger effect of the difference of
iHOT score and the HOS score between the groups
shown in Table 1. This suggests that even with only 12
questions the iHOT12 seems to have a high discrimin-
atory power. This indicates a reasonable ability to trans-
form a qualitative effect into a quantitative. Using the
method by Norman is controversial in literature [4, 7,
21, 37, 38]. Norman et al. [28] suggested an estimation
of the MIC by division of the standard deviation by two.
This method was derived from the effect size when
undergoing clinical intervention. Based on Terwee et al.
[25] a positive rating for responsiveness can be assumed
when SDC is greater than MIC. With an anchor based
method the patient’s report a current state of health tar-
geting for their personal expectations [4, 37, 38]. There-
fore, calculation of MIC can be problematic in absence
of a therapeutic gold standard. The COSMIN checklist
does not contain any recommendations on the estima-
tion of the MIC. Still, there is no consensus about how
to assess the MIC. Although the 95 % CI of the
“unchanged” and “somewhat better” group are wide, a
remarkable difference exists only within a small range of
0.18-0.55. The cut-off point that separates the “un-
changed” group from the “somewhat better” group has
to be outside of the 95 % CI of the “unchanged” group.
It should also represent the smallest acceptable effect
size for the “somewhat better” group. Accordingly, an es-
timated ES of 0.55 seems reasonable to approximate the
true ES of the iHOT12. Consequently, the minimal im-
portant change that reflects a clinically relevant
improvement is less than 14 points on the iHOT12.
Defining the MIC of the iHOT12 is a main aspect of this
study.
Our findings according to the global rating of change
also confirm a strong correlation between patient per-
ception and score result of the iHOT12.
Limitations
Despite good results concerning validity, reliability, and
responsiveness of the iHOT12, there are some limita-
tions to this study. Due to a lack of a therapeutic gold
standard, the minimal important change could only be
estimated. To date, the only study providing longitudinal
results on the iHOT is Mas Martinez et al. [8]. They re-
port on short term outcomes after hip arthroscopy in
FAI with a minimum follow up of 12 months. Unfortu-
nately, data concerning minimal clinically important
change are not specified in this study. Further
Fig. 5 Change scores for iHOT12 and iHOT33
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prospective studies on longitudinal measurement prop-
erties of the iHOT12 are needed.
Conclusion
The German version of the iHOT12 provides good val-
idity, reliability, and responsiveness for the functional
evaluation of physically active patients with a hip dis-
order. This is the first study to define the minimal im-
portant change (MIC) which less than 14 points on the
iHOT12 scale. The COSMIN checklist is a feasible
guideline to assess psychometric properties of patient re-
ported outcome measurements.
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